Toxicological methods for tracing drug abuse: Chromatographic, spectroscopic and biological characterisation of ecstasy derivatives

Arhiv za Higijenu Rada i Toksikologiju

Volumn 61, Issue 1, 2010, Pages 53-59

  Belhadj Tahar, Hafid ^a,b   Payoux, Pierre ^b   Tafani, Mathieu ^b   Coulais, Yvon ^b   Calet, Serge ^c   Bousseksou, Azzedine ^d  

^a CHU PURPAN   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c Laboratoire Holis Technologies   (France)

^d LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

Author keywords

IR; MDA; MDMA; MDNP; NMR; Raman; Toxicology

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; 3,4 METHYLENDIOXYPHENYL 2 NITROPROPENE; 3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALUMINUM LITHIUM HYDRIDE; AMMONIUM ACETATE; ANTIBODY; CHEMICAL AGENT; ECSTASY; ETHYLAMINE; ILLICIT DRUG; NEUROTOXIN; NITROETHANE; PIPERONAL; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; BIOLOGICAL TRAIT; BLOOD; BLOOD CELL; CHEMICAL STRUCTURE; DRUG ABUSE; DRUG SYNTHESIS; FLUORESCENCE POLARIZATION IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTITION COEFFICIENT; PLASMA PROTEIN BINDING; RAMAN SPECTROMETRY; STEREOISOMERISM; TOXICOLOGICAL PARAMETERS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SPECTROPHOTOMETRY, INFRARED; SPECTRUM ANALYSIS, RAMAN; SUBSTANCE ABUSE DETECTION;

EID: 77950240280     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/10004-1254-61-2010-1937     Document Type: Article

References (13)

1. Leung KS, Cottler LB. Ecstasy and other club drugs: a review of recent epidemiologic studies. Curr Opin Psychiatry 2008;21:234-241
2. Belhadj-Tahar H, Molnar Y, Payoux P, Coulais Y, Costes JP, Robert L, Esquerre JP, Bousseksou A. Contribution of the Raman spectroscopy in the characterization of ecstasy derivatives. In: 40th International Meeting of The International Association of Forensic Toxicologists (TIAFT), Paris, France, August 26-30th . Paris: TIAFT; 2002
3. Cheng JY, Chan MF, Chan TW, Hung MY. Impurity profiling of ecstasy tablets seized in Hong Kong by gas chromatography-mass spectrometry. Forensic Sci Int 2006;16:87-94.
4. Belhadj-Tahar H, Houin G, Frances B, Molnar G, Zwick A, Bousseksou A, Costes JP, Esquerre JP, Coulais Y. Relationship between chemical structure of ecstasy and positive response to fluorescence polarisation immunoassay: Interest of 1H, 13C RMN, IR, and Raman spectrocopic methods [Relation entre structure chimique et positivite du depistage de l'ecstasy par immunochimie FPIA: interet des spectroscopies 1H, 13C RMN, IR et Raman, in French]. Annales de Toxicologie Analytique 2003;17:179-180
5. Smith WE. Practical understanding and use of surface enhanced Raman scattering/surface enhanced resonance Raman scattering in chemical and biological analysis. Chem Soc Rev 2008;37:955-964
6. Bell SE, Spence SJ. Disposable, stable media for reproducible surface-enhanced Raman spectroscopy. Analyst 2001;126:1-3.
7. Bousseksou A, McGarvey JJ, Varret F, Real JA, Tuchagues JP, Dennis AC, Boillot ML. Raman spectroscopy of the high- and low-spin states of the spin crossover complex Fe(phen)2(NCS)2: an initial approach to estimation of vibrational contributions to the associated entropy change. Chem Phys Lett 2000;318:409-416
8. Bell SE, Fido LA, Sirimuthu NM, Speers SJ, Peters KL, Cosbey SH. Screening tablets for DOB using surfaceenhanced Raman spectroscopy. J Forensic Sci 2007;52:1063-1067
9. Milhazes N, Martins P, Uriarte E, Garrido J, Calheiros R, Marques MP, Borges F. Electrochemical and spectroscopic characterisation of amphetamine-like drugs: application to the screening of 3,4-methylenedioxymethamphetamine (MDMA) and its synthetic precursors. Anal Chim Acta 2007;596:231-241
10. Bonhommeau S, Molnar G, Galet A, Zwick A, Real JA, McGarvey JJ, Bousseksou A. One shot laser pulse induced reversible spin transition in the spin-crossover complex [Fe(C4H4N2){Pt(CN)4}] at room temperature. Angew Chem Int Ed Engl 2005;44:4069-4073
11. Nichols DE, Hoffman AJ, Oberlender RA, Jacob P, Shulgin AT. Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class. J Med Chem 1986;29:2009-2015
12. Belhadj-Tahar H, Boumahdi R, Darbieu MH. Conceptionalization of diagnostic agents: From empirical in vivo screening to rational in vitro predictive parameters. Altern Lab Anim 2000;28:303-314
13. Mrkvickova Z, Kovarikova P, Balikova S, Klimes J. Determination of lipophilicity of novel potential antituberculotic agents using HPLC on monolithic stationary phase and theoretical calculations. J Pharm Biomed Anal 2008;48:310-314